Terms: = Kidney tumors AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Diagnosis
3 results:
1. Non-invasive Detection of Immunotherapy-Induced Adverse Events.
Ferreira CA; Heidari P; Ataeinia B; Sinevici N; Sise ME; Colvin RB; Wehrenberg-Klee E; Mahmood U
Clin Cancer Res; 2021 Oct; 27(19):5353-5364. PubMed ID: 34253581
[TBL] [Abstract] [Full Text] [Related]
2. Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases.
Steindl A; Alpar D; Heller G; Mair MJ; Gatterbauer B; Dieckmann K; Widhalm G; Hainfellner JA; Schmidinger M; Bock C; Müllauer L; Preusser M; Berghoff AS
ESMO Open; 2021 Apr; 6(2):100057. PubMed ID: 33588158
[TBL] [Abstract] [Full Text] [Related]
3. Expression and prognostic role of MEKK3 and pERK in patients with renal clear cell carcinoma.
Chen Q; Lu HS; Gan MF; Chen LX; He K; Fan GM; Cao XQ
Asian Pac J Cancer Prev; 2015; 16(6):2495-9. PubMed ID: 25824786
[TBL] [Abstract] [Full Text] [Related]
